Lee, Chung-Han https://orcid.org/0000-0001-5511-0635
Motzer, Robert J. https://orcid.org/0000-0001-6925-2327
Article History
First Online: 11 December 2018
Competing interests
: C.-H.L. has received consulting fees from Eisai and Exelixis, research money and/or grants from Bristol Myers Squibb, Calithera, Eisai, Exelixis and Pfizer. R.J.M. has received consulting fees from Pfizer, Genentech/Roche, Merck, Incyte, Eisai, Exelixis and Novartis, and research money and/or grants from Bristol Myers Squibb, Pfizer, Genentech/Roche and Eisai.